| Abstrakt: |
B Results: b In total, 80 dogs (30 healthy, 16 dogs in IRIS stage 1, 25 dogs in stage 2, and 9 dogs in stage 3 or 4) were included. B Objectives: b To evaluate if serum amyloid A (SAA), together with cat characteristics and other circulating biomarkers, can be used to differentiate cats with suspected lipidosis from cats with other liver diseases. The dogs were allocated into four groups: (i) dogs with DM (group DM), (ii) dogs with hyperadrenocorticism (group HAC), (iii) dogs on corticosteroid therapy for >2 weeks (CST), and (iv) dogs with various diseases (group VD). 49 Zoomics: Comparative metabolomics of red blood cells from dogs, cows, horses, and donkeys dur... Arianna Miglio 1, Mark Maslanka 2, Morena Di Tommaso 3, Francesca Rocconi 3, Travis Nemko... 1 Department of Veterinary Medicine, University of Perugia, Italy; 2 Department of Biochemist... B Background: b The use of omics technologies in human transfusion medicine has improved our understanding of red blood cell (RBC) storage lesions. [Extracted from the article] |
Plný text